Cargando…
Glucocorticoid-induced leucine zipper (GILZ)/NF-κB interaction: role of GILZ homo-dimerization and C-terminal domain
Glucocorticoid-induced leucine zipper (GILZ) is a 137 amino acid protein, rapidly induced by treatment with glucocorticoids (GC), characterized by a leucine zipper (LZ) domain (76–97 amino acids), an N-terminal domain (1–75 amino acids) and a C-terminal PER domain (98–137 amino acids) rich in prolin...
Autores principales: | Marco, Barbara Di, Massetti, Michela, Bruscoli, Stefano, Macchiarulo, Antonio, Virgilio, Rosa Di, Velardi, Enrico, Donato, Valerio, Migliorati, Graziella, Riccardi, Carlo |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1802615/ https://www.ncbi.nlm.nih.gov/pubmed/17169985 http://dx.doi.org/10.1093/nar/gkl1080 |
Ejemplares similares
-
Glucocorticoid-Induced Leucine Zipper (GILZ) in Cardiovascular Health and Disease
por: Cappetta, Donato, et al.
Publicado: (2021) -
Expression of concern on ‘glucocorticoid-induced leucine zipper (GILZ)/NF-κB interaction: role of GILZ homo-dimerization and C-terminal domain’
Publicado: (2022) -
Editor's Note on ‘Glucocorticoid-induced leucine zipper (GILZ)/NF-κB
interaction: role of GILZ homo-dimerization and C-terminal domain’
Publicado: (2023) -
Glucocorticoids and Glucocorticoid-Induced-Leucine-Zipper (GILZ) in Psoriasis
por: Sevilla, Lisa M., et al.
Publicado: (2019) -
Anti-Inflammatory Effects of Synthetic Peptides Based on Glucocorticoid-Induced Leucine Zipper (GILZ) Protein for the Treatment of Inflammatory Bowel Diseases (IBDs)
por: Paglialunga, Musetta, et al.
Publicado: (2023)